OP07.11: Evaluation of the ovarian‐adnexal reporting and data system in discriminating benign from malignant adnexal lesions

Abstract

Short oral presentation abstractsMethods: As the pandemic is going on for more than 2 years now enough data has been collected to make a comparison regarding the management of adnexal masses in relation to the non-COVID (before March, 2020) times. One year have picked from both era from a tertiary university hospital's gynecological ultrasound outpatient's data and have been analysed regarding patient and tumour characteristics including ADNEX score. Results: During the non-COVID interval 340 patients were examined of which 32 underwent regular follow-ups while 150 patients were operated on. From the operated group 145 patients (avg: 42.04yrs, 15-83yrs) have been included in the analysis (5 adolescents were excluded). In contrast during the COVID interval 211 patients (avg: 49.73yrs, 15-7yrs) have been examined of which 13 was followed up at least two times while 40 patients underwent operation. The ADNEX score of the COVID group was significantly higher than the other. The same correlation has been found in the patient age of the operated groups: COVID era patients proved to be older. However much higher portion of masses turned out to carry malignancy in the COVID group: 35.0% versus 13.1% respectively. Conclusions: Patient selection is crucial in those cases when the operation limits are set to extremely low limits. Preoperative ultrasound imaging combined with ADNEX model proved to be a successful and very powerful technique finding the best and most accurate method for patient with adnexal masses.